Send to

Choose Destination
Nat Med. 1996 Oct;2(10):1096-103.

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.

Author information

Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas 75325, USA.

Erratum in

  • Nat Med 1996 Nov;2(11):1267.


Inadequate presentation of tumor antigens by host professional antigen-presenting cells (APCs), including dendritic cells (DCs), is one potential mechanism for the escape of tumors from the host immune system. Here, we show that human cancer cell lines release a soluble factor or factors that dramatically affect DC maturation from precursors without affecting the function of relatively mature DCs. One factor responsible for these effects was identified as vascular endothelial growth factor (VEGF). Thus, VEGF may play a broader role in the pathogenesis of cancer than was previously thought, and therapeutic blockade of VEGF action may improve prospects for immunotherapy as well as inhibit tumor neovasculature.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center